We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Edible Toothpaste-Based Transistor to Power Future Smart Pills for Monitoring Health Conditions

By HospiMedica International staff writers
Posted on 27 Sep 2024

Future smart pills are being developed to monitor health conditions from inside the body and dissolve safely after completing their task. More...

Now, a breakthrough in edible electronics in the form of a toothpaste-based transistor could become a key component of these smart pills.

Many commercial toothpaste products contain crystals of copper phthalocyanine, a blue pigment used as a whitening agent. This pigment adheres to teeth, functioning as an optical filter to enhance their whiteness, and is gradually ingested throughout the day as it is removed by saliva. Researchers at the IIT-Italian Institute of Technology (Milan, Italy) studied the properties of copper phthalocyanine and, through lab simulations and analysis of existing clinical data, determined that on average, people ingest about 1 milligram of this substance every time they brush their teeth. With the amount ingested daily, it is theoretically possible to create around 10,000 edible transistors.

What makes copper phthalocyanine particularly interesting is its chemical structure, which supports charge conduction within its crystals, making it an ideal candidate for use as a semiconductor in organic electronics. The research team incorporated this pigment as a semiconductor into an existing formula for building edible circuits. These circuits are constructed on an ethylcellulose substrate, with electrical contacts printed using inkjet technology and a gold particle solution, commonly used in culinary decoration. A "gate" made from an electrolytic gel based on chitosan, a food-grade gelling agent derived from crustaceans like blue crabs, allows the transistor to function at a low voltage of less than 1V, according to the findings published in Advanced Science.

The next goal for the research team is to identify additional edible materials with suitable chemical and physical properties to create intelligent, ingestible electronic devices that could be used in healthcare applications, such as monitoring internal body parameters within the gastrointestinal tract.


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Warming Cabinet
EC1850BL
New
Pressure Transducer
TruWave
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.